Although
both clinical observation and model studies showed that stimulation of GB34
acupoint improved motor function in Parkinson’s, its mechanism behind is
unclear. Very recently two reports of PD model studies shed the light on the
question.
Dr.
Tian and colleagues in China investigated the effect and mechanism of
stimulating GB34 in PD model. They observed first that there was an aggregation
of toxic protein, alpha-synuclein closely linked to PD, in the dopamine cells
in the brain of PD model. Stimulation at GB34 promoted the autophagic clearance
of alpha-synuclein, in a manner different from mammalian target of rapamycin
(mTOR)-dependent pathway. Further improvement in the motor function at the
behavior level of model was observed. Authors suggested that connection between
acupuncture and autophagy not only provides a new route to understanding the
molecular mechanism of acupuncture treatment in Parkinson’s.
Later,
Dr. Park and colleagues in Korea conducted a series of in vitro and in vivo
studies of Parkinson’s. Firstly they found that melanin-concentrating hormone
(MCH) in hypothalamus of brain is a neuroprotective agent, then that MCH
protected dopamine cells in both vitro and vivo studies. Further stimulation at
GB34 activated hypothalamic MCH biosynthesis which can be blocked by MCH-R1
antagonist, then releasing MCH-activated MCH receptors (MCH-Rs) in the dopamine
terminals, and showed dopaminergic neuroprotection. MCH is an important metabolic
hormone that reportedly influences sleep control and affects learning and
memory. About 80 % of patients with PD experienced sleep disturbances, and they
showed substantial losses of MCH neurons in the hypothalamus. Moreover, this
loss of MCH neurons has been significantly correlated with the clinical stages
of PD and regarded as hypothalamic dysfunction in PD. This study suggested that
acupuncture stimulation at GB34 activated MCH may play an important role in
neuroprotection of Parkinson’s.
References
Tian
T et al., Acupuncture promotes mTOR-independent autophagic clearance
of aggregation-prone
proteins in mouse brain. Sci Rep. 2016 Jan 21;6:19714. http://www.nature.com/articles/srep19714Park JY et al., Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson’s Disease. Mol Neurobiol. 2016 Nov 14. https://www.ncbi.nlm.nih.gov/pubmed/27844281
No comments:
Post a Comment